BJDX

Bluejay Diagnostics, Inc.

3.09 USD
+0.08 (+2.66%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Bluejay Diagnostics, Inc. stock is down -22.36% since 30 days ago. The next earnings date is Aug 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 June’s closed higher than May.

About Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc. develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis.